Kilambi News
Saturday, October 10, 2026

TA exits Rocscience in $535 million Hexagon sale

Infrastructure Saturday, October 10, 2026 · Updated Oct 10, 2026 07:10

TA Associates agreed to sell its portfolio company Rocscience, a geotechnical engineering software maker, to Swedish industrial group Hexagon at an enterprise value of about $535 million.

Why it matters: Another PE-to-strategic exit in industrial software shows large industrial owners paying up for engineering-tools businesses that sit inside mining and civil infrastructure workflows.

Data as of Agreement announced October 9, 2026 (TA release). Terms per the seller's announcement; Hexagon confirmation not yet seen.

TA Associates will fully exit Rocscience, its geotechnical and engineering software portfolio company, under an agreement to sell the business to Hexagon AB at an enterprise value of about $535 million. TA became the company’s first institutional investor in June 2023.

Rocscience, founded as an independent company in 1996 by Dr. John Curran at the University of Toronto, makes 2D and 3D software that models how rock, soil and structures behave, used in mining, civil and structural engineering design and decision-making. During TA’s hold, the company expanded its product suite, invested in go-to-market operations, added AI-enabled product innovation including a natural-language interface, and made six acquisitions: DIANA FEA, 3GSM, DEEPSOIL, 2SI, Rockfield and Aquanty.

The sale continues this week’s run of private-equity exits to strategic buyers: alongside GE HealthCare’s $945 million purchase of Trilantic-backed SOFIE Biosciences, sponsor-owned industrial and infrastructure-adjacent businesses are finding buyers in corporates willing to pay for embedded positions in engineering and manufacturing workflows.

Sources

  1. TA Portfolio Company Rocscience to be Acquired by Hexagon · TA Associates (via Business Wire) · 2026-10-09
  2. Apollo, Kohlberg, Montagu pursue surgical equipment providers; Radiopharma boom aids Trilantic North America's $945m SOFIE Biosciences exit · PE Hub · 2026-10-09